A Multigene Circulating Biomarker to Predict the Lack of FOLFIRINOX Response after a Single Cycle in Patients with Pancreatic Ductal Adenocarcinoma.
EUROPEAN JOURNAL OF CANCER(2023)
Key words
Pancreatic ductal adenocarcinoma (PDAC),FOLFIRINOX chemotherapy,Lack of response,Blood immune transcriptome,FFX-Delta GEP score,Precision medicine
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined